
Bluepear is an AI-powered brand and affiliate monitoring platform that helps marketing teams protect their brand in paid search (PPC). It continuously monitors branded search queries 24/7 across all geographies, device types, and search engines — including Google, Bing, Yahoo!, and Yandex — to detect unauthorized use of branded keywords, ad hijacking, coupon code abuse, and trademark violations by affiliates and competitors.
The platform automates detection of complex violations that manual audits routinely miss. Its uncloaking tool reveals actual landing pages and full redirect chains behind cloaked affiliate links, capturing screenshots and ad data as evidence. All findings are centralized in a single dashboard with instant alerts delivered via Slack, Telegram, or email, and structured compliance reports can be generated for every incident.
Bluepear serves Paid Search/PPC teams, affiliate managers, and marketing compliance teams at brands in e-commerce, travel & ticketing, pharma, health & beauty, marketing agencies, iGaming, and IT/SaaS. Customers include Wargaming, vidaXL, Proton, MoneyGram, IQ Option, and Kilo Health.
Key capabilities include brand bidding protection, ad hijacking detection, coupon code monitoring, competitor keyword and ad copy tracking, progress status tracking for violation resolution, and global coverage down to city level. The platform supports custom data exports, policy-based filtering by violation type, and real-time research tools that compare advertiser dynamics, visibility rates, and keyword usage over time.
Bluepear offers a 7-day free trial with no credit card required, usage-based pricing, and is accessible on web, iOS, Android, and via API.
Learn more

Qualio is a purpose-built quality and compliance platform for life sciences companies operating in complex, high-stakes regulatory environments. Medical device, SaMD, biotech, and pharma teams use Qualio to replace fragmented eQMS tools, spreadsheets, and consultant-driven audits with a single, validated system that delivers continuous audit and inspection readiness.
Qualio combines a modern eQMS with Compliance Intelligence—an AI-driven layer that continuously evaluates how well real operating data aligns with regulatory requirements. Instead of treating audits as one-off events, teams gain always-on visibility into compliance coverage, risk exposure, and readiness across FDA, ISO, EU MDR, GxP, and software-intensive standards.
Core quality workflows—document control, training, CAPA, change management, supplier quality, and design controls—are directly connected to regulatory obligations and objective evidence. Deep integrations with Jira, Azure DevOps, GitHub, TestRail, and Salesforce automatically capture proof from development and operational systems, eliminating manual evidence gathering and reducing compliance drag on engineering teams.
Compliance Intelligence runs multi-standard gap analysis in under an hour, flags emerging risks before they become findings or 483s, and maps reusable evidence across frameworks to accelerate submissions and market expansion. All insights are explainable and traceable back to specific clauses and internal policies, supporting validation and audit expectations.
The result: audit readiness in weeks instead of months, fewer fire drills, faster launches, and lower long-term compliance cost. Qualio turns compliance from a reactive burden into a predictable, scalable system.
Learn more
CoVigilAI
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Learn more
Dialog
Dialog provides a comprehensive, modular solution for pharmacovigilance literature monitoring, designed to enhance the efficiency of organizations responsible for drug safety reporting by automating and refining the entire process of literature triage. With access to over 140 reputable scientific and medical literature databases, including MEDLINE, Embase, and Biosis, it standardizes the content from various sources, ensuring a consistent approach to precision search, deduplication, and structured XML output. The DialogML engine utilizes advanced artificial intelligence to prioritize search results based on their relevance to patient safety, identifies critical safety concepts, and categorizes references pertinent to ICSRs (Individual Case Safety Reporting), aggregated reports (PBRER, PSUR, DSUR), and safety signals, enabling reviewers to swiftly pinpoint high-priority articles. Furthermore, the Dialog Alerts Manager enhances the process of creating and managing alerts by providing features such as bulk editing options, comprehensive audit trails for changes in search strategies, flexible scheduling, and detailed tracking of delivery histories. This integrated system significantly reduces the time and effort required for effective literature monitoring, empowering organizations to focus more on critical drug safety issues.
Learn more